Details
Stereochemistry | UNKNOWN |
Molecular Formula | C12H14N2O3 |
Molecular Weight | 234.2512 |
Optical Activity | ( + ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC2=CC=CC=C2C(=O)N1CC(O)CO
InChI
InChIKey=NTGLQWGMESPVBV-UHFFFAOYSA-N
InChI=1S/C12H14N2O3/c1-8-13-11-5-3-2-4-10(11)12(17)14(8)6-9(16)7-15/h2-5,9,15-16H,6-7H2,1H3
Molecular Formula | C12H14N2O3 |
Molecular Weight | 234.2512 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Diproqualone was used primarily for the treatment of inflammatory pain associated with osteoarthritis. The analgesic activity of diproqualoneis synergistic with that of noramidopyrine. It also display anti-inflammatory action in the rat, inhibiting plantar edema with dextran or serotonin, atopic edema from ovalbumin, etc. It has spasmolytic, anticholinergic and antihistaminic action in higher doses. It is not hypnotic and has no anticonvulsant effects. The therapeutic symptoms for diproqualone are all types of pain: postoperative, posttraumatic, dental, neuritis, anti-inflammatory arthritis, etc.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:17:56 GMT 2023
by
admin
on
Sat Dec 16 11:17:56 GMT 2023
|
Record UNII |
L2Y2CV3EW7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
46800-89-9
Created by
admin on Sat Dec 16 11:17:56 GMT 2023 , Edited by admin on Sat Dec 16 11:17:56 GMT 2023
|
PRIMARY | |||
|
64112
Created by
admin on Sat Dec 16 11:17:56 GMT 2023 , Edited by admin on Sat Dec 16 11:17:56 GMT 2023
|
PRIMARY | |||
|
L2Y2CV3EW7
Created by
admin on Sat Dec 16 11:17:56 GMT 2023 , Edited by admin on Sat Dec 16 11:17:56 GMT 2023
|
PRIMARY |